Immatics N.V.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMTX research report →
About the company
Immatics N. V. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing T-cell receptor (TCR) based immunotherapies aimed at combating cancer, primarily within the United States.
- CEO
- Harpreet Singh
- IPO
- 2018
- Employees
- 554
- HQ
- Tübingen, DE
Price Chart
- Market Cap
- $1.33B
- P/E
- -5.09
- P/S
- 31.27
- P/B
- 2.57
- EV/EBITDA
- -4.35
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -570.30%
- Net Margin
- -574.86%
- ROE
- -45.27%
- ROIC
- -43.12%
- Revenue
- $48.27M · -69.03%
- Net Income
- $-196,447,000 · -1390.89%
- EPS
- $-1.54 · -1200.00%
- Op Income
- $-182,016,000
- FCF YoY
- -0.83%
- 52W High
- $12.41
- 52W Low
- $5.05
- 50D MA
- $10.51
- 200D MA
- $9.98
- Beta
- 1.32
- Avg Volume
- 464.35K
Get TickerSpark's AI analysis on IMTX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 16, 26 | Stone Adam Leo | other | 48,000 |
| Jun 16, 26 | REICIN ALISE | other | 48,000 |
| Jun 16, 26 | ATIEH MICHAEL G | other | 48,000 |
| Jun 16, 26 | Carter Paul Rutherford | other | 48,000 |
| Jun 16, 26 | Forster Eliot | other | 48,000 |
| Jun 16, 26 | Chambre Peter Alan | other | 48,000 |
| Jun 16, 26 | Mason Heather L | other | 48,000 |
| Jun 16, 26 | PERCEPTIVE ADVISORS LLC | other | 48,000 |
| Jun 16, 26 | Hothum Mathias | other | 48,000 |
| Mar 18, 26 | Reinhardt Carsten Alexander Johannes | other | 0 |
Our IMTX coverage
Recent articles, reports, and earnings notes.
No research on IMTX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IMTX report →Similar companies
Peers in the same neighborhood.